(2E)-1-(3,4-dichlorophenyl)-3-(2,3-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 10g

4-Bromo-1-methyl-1H-pyrazole-3-carbaldehyde, 95.0%, 50g

3-(3,4-Dihydroxyphenyl)-2-oxopropanoic acid, 95.0%, 100mg

(E)-6-Bromo-3-(6-bromo-1-(2-octyldodecyl)-2-oxoindolin-3-ylidene)-1-(2-octyldodecyl)indolin-2-one, 97%, 250mg

2,2-Dimethyl-6-nitro-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one, 95.0%, 250mg

Hidróxido de magnesio, mínimo 95%, Ph.Eur., 500 g, envase de plástico.

Boc-L-isoleucine hemihydrate, 96.0%, 1g

4,4'-(1,3-Phenylenebis(oxy))diphenol, 95%, 100mg

N-CYCLOHEXYL-N-METHYL-4-(1,2-DIHYDRO-2-OXO-6-QUINOLYLOXY)BUTYRAMIDE, 95%, 1g

2-(3-Bromophenyl)azetidine hydrochloride, 98%, 10g

(4-((Trifluoromethyl)thio)phenyl)boronic acid, 95+%, 25g

[1,1'-Biphenyl]-3,4'-diyldimethanol, 96%, 1g

N,O-Bis(tert-butyldimethylsilyl)acetamide [tert-Butyldimethylsilylating Agent]>96.0%(GC)5g